Found: 5
Select item for more details and to access through your institution.
Gender-specific differences in patients with psoriatic arthritis receiving ustekinumab or tumour necrosis factor inhibitor: real-world data.
- Published in:
- Rheumatology, 2023, v. 62, n. 10, p. 3382, doi. 10.1093/rheumatology/kead089
- By:
- Publication type:
- Article
Minimal disease activity (MDA) in patients with recent-onset psoriatic arthritis: predictive model based on machine learning.
- Published in:
- Arthritis Research & Therapy, 2022, v. 24, n. 1, p. 1, doi. 10.1186/s13075-022-02838-2
- By:
- Publication type:
- Article
Improvement in patient-reported outcomes and work productivity following 3-year ustekinumab or tumour necrosis factor inhibitor treatment in patients with psoriatic arthritis: results from the PsABio real-world study.
- Published in:
- Arthritis Research & Therapy, 2023, v. 25, n. 1, p. 1, doi. 10.1186/s13075-023-03058-y
- By:
- Publication type:
- Article
Dual targeted therapy in patients with psoriatic arthritis and spondyloarthritis: a real-world multicenter experience from Spain.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1283251
- By:
- Publication type:
- Article
Moderate-High Disease Activity in Patients with Recent-Onset Psoriatic Arthritis—Multivariable Prediction Model Based on Machine Learning.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 3, p. 931, doi. 10.3390/jcm12030931
- By:
- Publication type:
- Article